Mog Antibody-Associated Disease

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

Mayo Clinic Laboratories

2018 RNDS — MOG Antibody-Associated Disease

SRNA

Are You Missing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD)?

912. MOG Antibody Disease: Diagnosis and Treatment Guidelines

SRNA

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and NMOSDs

Neurology Journal

702. Pediatric MOG Antibody-Associated Disease and ADEM

SRNA

605. What is MOG antibody-associated disease?

SRNA

2019 RNDS — Session on the Diagnosis and Treatment of MOG Antibody-Associated Disease

SRNA

Recognizing the Clinical Features of MOGAD for Diagnosis

Features of MOG required for recognition by patients with MOG antibody-associated disorders

Research developments in MOGAD

MOGAD (Myelin Oligodendrocyte Glycoprotein Associated Disease) Explained by Neurologist

Dr. Brandon Beaber

2022 Pre-RNDS | MOG Antibody Disease (MOGAD)

SRNA

MOG antibody associated disease (MOG)

Neurology with Pushkar 🧠

Myelin Oligodendrocyte Glycoprotein (MOG)

Neuro-Ophthalmology with Dr. Andrew G. Lee

2020 RNDS | What is MOG Antibody Disease (MOGAD)?

SRNA

Clinical Trial: Rozanolixizumab for MOG Antibody-associated Disease (NCT05063162)

Power Life Sciences

The pathology of MS and MOGAD: similarities and differences

Current MOGAD criteria and the role of MRI in diagnosis

MOG antibody seropositivity in a multi-ethnic population